🟢 Immunitybio is trading 4.51% up today with biotech-sector support; no direct catalyst identified

Immunitybio is trading at $8.80, up 4.51%, with biotech-sector gains offering support; no direct cause for the session’s move has been established.

• The biotech sector is up 2.10% in the regular session, while broader-market indices are mixed.
• No fresh company-specific catalyst surfaced for October 20. Recent positive announcements were the October 14 ANKTIVA label expansion and October 16 clinical data update; available sources do not establish them as the cause of today’s gain.